Pulmonary blastoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Pulmonary blastoma.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Pulmonary blastoma.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

XARELTO

(RIVAROXABAN)standard

Janssen Pharmaceuticals, Inc.

Factor Xa Inhibitor [EPC]

12.1 Mechanism of Action XARELTO is a selective inhibitor of FXa. It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Pulmonary blastoma.
Search all trials →
Search clinical trials for Pulmonary blastoma

Recent News & Research

No recent news articles indexed yet for Pulmonary blastoma.
Search PubMed for Pulmonary blastoma

Browse all Pulmonary blastoma news →

Specialist Network

Top 6 by expertise

View all Pulmonary blastoma specialists →

Quick Actions